AAPM 2020 Session to Explain the Risks and Benefits of Cannabis Use for Pain Treatment
Join moderator Mark S. Wallace, MD, on Friday, February 28, 11 am-12 pm, during the AAPM 36th Annual Meeting in National Harbor for a session dedicated to helping pain care providers unpack the evidence and indications for TCH/CBD treatments. Dr. Wallace is professor of clinical anesthesiology and the chair, division of pain medicine in the department of anesthesiology, UCSD School of Medicine.
In 2018, the United States opioid epidemic raged with more than 45,000 overdose deaths. Pain clinicians and patients are increasingly turning to alternative, non-opioid treatments to combat acute and chronic pain, including cannabis products. The strength of evidence to support using cannabis to treat pain is not widely understood. This session will review the available evidence and includes a talk from Dr. Wallace that specifically addresses the question of whether cannabis should be used to reduce opioid use.
Understanding the biology of the endocannabinoid system
The February 28 session will also address the biology of cannabis. David A. Edwards, MD PhD, chief of the division of pain medicine at Vanderbilt, will deliver a talk that discusses how exogenous cannabinoids are hypothesized to treat pain.
What about CBD oil for pain?
The U.S. marketplace has been flooded with CBD oil products that are promoted for all kinds of uses, including pain management. Thomas P. Pittelkow, DO MPH, assistant professor of anesthesiology in the division of pain medicine at Mayo Clinic in Rochester, MN, will speak directly to the risks and benefits of CBD oil for pain.
Registration for the meeting is live, and early-bird rates end January 8, 2020.